24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

University of Sao Paulo

Status: Completed

Conditions: Sports Nutritional Physiological Phenomena

Treatments: Dietary Supplement: Beta-alanine; Dietary Supplement: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT03655041

24WKBA

Details and patient eligibility

About

Although β-alanine (BA) has been shown to be an effective ergogenic aid, little information exists on the safety of chronic supplementation despite potential concerns. The aim of this study was to investigate the effects of chronic BA supplementation on muscle taurine content, blood clinical markers and sensory side-effects during 24 weeks of BA supplementation.

Enrollment: 25 patients

Sex: Male

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy males

Exclusion criteria

• Smokers
• Chronic disease
• Prior or current use of steroids
• Use of creatine in the last 6 months
• Use of beta-alanine in the last 6 months

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

25 participants in 2 patient groups, including a placebo group

Beta-Alanine

Experimental group

Description:

6.4 g/day of beta-alanine for 24 weeks

Treatment:

Dietary Supplement: Beta-alanine

Placebo

Placebo Comparator group

Description:

6.4 g/day of maltodextrin for 24 weeks

Treatment:

Dietary Supplement: Placebo